Ignite Creation Date:
2025-12-24 @ 6:38 PM
Ignite Modification Date:
2026-01-04 @ 11:25 PM
Study NCT ID:
NCT07009457
Status:
RECRUITING
Last Update Posted:
2025-07-04
First Post:
2025-05-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Clinical Study of SHR-1316 (SC) Combined With Carboplatin and Etoposide as First-line Treatment for Extensive Stage Small Cell Lung Cancer
Sponsor:
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-06-16
Start Date Type:
ACTUAL
Primary Completion Date:
2025-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-09
Completion Date Type:
ESTIMATED
First Submit Date:
2025-05-29
First Submit QC Date:
None
Study First Post Date:
2025-06-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-07-02
Last Update Post Date:
2025-07-04
Last Update Post Date Type:
ACTUAL